ClinicalTrials.govpublic full text
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
renal cell carcinoma, gastrointestinal stromal tumor, angiogenesis, inhibitor, duration of therapy, gist, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828885
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.